NeuroQore

Mountain View, CA · Founded 2012 · Privately Held (backing)

Developer of neuromodulation treatment systems designed to address depressive disorder and suicidality. NeuroQore is based in Mountain View, CA and was founded in 2012. It was valued at $10.6 million at its seed round in Sep 2025, the last priced event on record. It has raised $1.7 million across 1 recorded round; the latest was a $1.5 million seed round in Jul 2025.

PMV mark · valuation
$10.6M
Oct 2026
Priced at
its seed round
Sep 2025
Total raised
$1.7M
Last round
Seed Round
Jul 2025
How much has NeuroQore raised?
$1.7Macross 1 recorded rounds · Jul 2025 – Jul 2025

Most recently, NeuroQore raised $1.5M in its Seed Round (Jul 2025).

Free account
More of NeuroQore with a free account
  • ·Watch NeuroQore: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

NeuroQore round by round

1 rounds
Jul 2025Seed Round$1.5MSEC filing▮
2 investors participated

How much has NeuroQore raised?

NeuroQore has raised $1.7 million across 1 recorded round since 2025. The largest was a $1.5 million seed round in Jul 2025.

NeuroQore has filed 1 Form D with the SEC, most recently in Sep 2025 ($1.5 million sold to 2 investors).

NeuroQore investors

5 investors are on record for NeuroQore, including SOSV, IndieBio, Texas Medical Center and Federal Economic Development Agency for Southern Ontario. The seed round in Jul 2025 drew 2 investors.

For fundraisers
Raising for a company like NeuroQore?

5 investors have backed NeuroQore.

See all 5 investors →

Frequently asked about NeuroQore

How much has NeuroQore raised?
NeuroQore has raised $1.7M in total across 1 recorded funding rounds.
When was NeuroQore's last funding round?
NeuroQore's most recent recorded round was Seed Round in Jul 2025, raising $1.5M.